Gene Therapy

Edited by: Karen Young Kreeger Exposing Adenoviruses: Inder Verma and colleagues used nude mice to study immune system and humoral responses during gene therapy. Y. Dai, E.M. Schwartz, D. Gu, W.-W. Zhang, N. Sarvetnick, I.M. Verma, "Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens for long-term expression," Proceedings of the National Academy of Sciences, 92:1401-5, 1995. (Cited in nearly 60 publications as of

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by: Karen Young Kreeger


Exposing Adenoviruses: Inder Verma and colleagues used nude mice to study immune system and humoral responses during gene therapy.
Y. Dai, E.M. Schwartz, D. Gu, W.-W. Zhang, N. Sarvetnick, I.M. Verma, "Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens for long-term expression," Proceedings of the National Academy of Sciences, 92:1401-5, 1995. (Cited in nearly 60 publications as of December 1996)

Comments by Inder M. Verma, Salk Institute, San Diego

For the last few years, gene therapists have focused their attention on recombinant adenoviruses to deliver genes to cells in vivo. But in several studies, these vectors impart only short-lived expression of the desired therapy. Investigators surmised that the host immune system was responsible for preventing prolonged expression of the foreign genes carried by the adenoviral vectors.

A group led by Inder M. Verma, American ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies